American College of Sports Medicine to Hear Results of Study at Annual Meeting SAN FRANCISCO–(BUSINESS WIRE)–May 30, 2003– A topical cream composed of cetylated fatty acids (CFA) can improve quality of life and mobility in patients with osteoarthritis, according to a study conducted by the University of Connecticut and Imagenetix (OTCBB:IAGX – News), and slated [...]

{ Comments on this entry are closed }

Imagenetix Expands Marketing Efforts

by Imagenetix on April 28, 2003

SAN DIEGO–(BUSINESS WIRE)–April 28, 2003–Imagenetix, Inc. (OTCBB: IAGX – News) announces that the Company has recently entered into several agreements with organizations to private label and distribute products to the mass markets. Initial test marketing of select private labeled products is scheduled to begin over the radio and through a television infomercial during the next [...]

{ Comments on this entry are closed }

San Diego based Imagenetix, Inc. www.imagenetix.net (OTCBB: IAGX) announces promising research on the bioavailability of a proprietary Imagenetix compound was detailed in a poster presentation at the Experimental Biology 2003 Conference in San Diego on Saturday, April 12. This compound is a proprietary fatty acid ester blend that has been shown in studies to significantly [...]

{ Comments on this entry are closed }

Imagenetix Files Patent on Genepril™

by Imagenetix on April 2, 2003

San Diego, CA – April 2, 2003 – Imagenetix, Inc. (OTC/BB: IAGX) announces the filing of a patent application with the U.S. Patent Office for its Genepril™ bioceutical composition. Imagenetix is seeking claims for the prevention and treatment of various types of arthritis and other inflammatory joint diseases as well as psoriasis, lupus, and cardiovascular [...]

{ Comments on this entry are closed }